Immunological and biological characteristics of a new TRF analogue, L-pyroglutamyl-L-histidyl-L-pipecolic acid amide.
The immunological and biological potencies of a new synthetic TRF analogue, L-pyroglutamyl-L-histidyl-L-pipecolic acid amide, were compared with those of TRF. In a radioimmunoassay system for TRF, parallel inhibition curves were obtained with TRF and the analogue, the immunological potency of the latter being approximately 50 per cent of the former. In vitro and in vivo TSH-releasing activities of the analogue were almost equal to those of TRF. As was observed with TRF, the in vitro TSH-releasing effect of the analogue was reduced in the presence of T4, and the analogue was inactivated by incubation with rat serum. The data suggest that the pyrrolidine ring of TRF can be replaced with piperidine ring without significant loss of the biological activity.
D000818:Animals; D066298:In Vitro Techniques; D008297:Male; D010875:Pipecolic Acids / Q000276:immunology; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D011863:Radioimmunoassay; D051381:Rats; D013972:Thyrotropin / Q000032:analysis; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000276:immunology / Q000494:pharmacology
D010875:Pipecolic Acids; D013973:Thyrotropin-Releasing Hormone; C014786:pyroglutamyl-L-histidyl-L-pipecolic acid amide; D013972:Thyrotropin; D011761:Pyrrolidonecarboxylic Acid